Ralphey, Sadly, all very true. AMRN is NOT proactive in defending their share price, protecting their patents, or confronting idiots like Nissen. The best way to protect against Nissen's stupidity would be to claim that that he is harming CVD patients by not accepting Vascepa as a beneficial drug. AMRN management & BOD are a laughing stock...What a waste of a great drug!